Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21306237 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors
Conditions: Carcinoma, Islet Cell;   Carcinoma, Pancreas
Interventions: Drug: sunitinib malate;   Drug: Placebo

Indicates status has not been verified in more than two years